AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BIOME AUSTRALIA LTD

0.275

+0.0051.85%

Volume:59.40K

Turnover:16.04K

Market Cap:62.42M

PE:65.48

High:0.275

Open:0.270

Low:0.267

Close:0.270

52wk High:0.560

52wk Low:0.200

Shares:227.00M

Float Shares:121.51M

Volume Ratio:0.39

T/O Rate:0.05%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.004

EPS(LYR):0.001

ROE:18.09%

ROA:3.02%

PB:10.30

PE(LYR):280.04

Loading ...

Overview Company News Filings

RBC Adjusts PT on Bio-Rad Laboratories to $390 From $370, Maintains Outperform Rating

MT Newswires Live

RBC Adjusts Price Target on Bio-Rad Laboratories to $370 From $320, Maintains Outperform Rating

MT Newswires Live

ASX Penny Stocks To Watch: Biome Australia And Two More Compelling Picks

Simply Wall St.

Biome Australia - FY26 Sales Revenue Rises 30% to A$23.9 Mln

THOMSON REUTERS

Bio Rad Laboratories (BIO) Launches New ddPCR Kits Following A Fair Value Debate

Simply Wall St.

Biome Australia Logs FY Revenue of AUD 23.9 Million

Biome Australia Hits Two-month High on Upbeat Full-year Sales Revenue

Biome Australia Logs FY Revenue of AUD 23.9 Million

Biome Australia Ltd - Vision 27 Targets Cumulative Sales Revenue of at Least A$75m Across FY25 to FY27

THOMSON REUTERS

Bio Protocol launches AI research hub to challenge grant gatekeepers

How Stronger Results and Institutional Selling At Bio-Rad Laboratories (BIO) Has Changed Its Investment Story

Simply Wall St.

Does New MicroVal Approval Clarify Bio-Rad (BIO)’s Competitive Edge in Food Safety Testing?

Simply Wall St.

ASX Penny Stocks With Market Caps Under A$200M To Watch

Simply Wall St.

Biome Signs Binding Commercial Manufacturing Agreement for Activated Probiotics Products in Australia

MT Newswires Live

BUZZ-Biome Australia soars on signing Australian manufacturing deal

Biome Australia - Signs Manufacturing Agreement to Bring Activated Probiotics Production Onshore

THOMSON REUTERS

Biome Australia - First Commercial Batch Targeted for September 2026

THOMSON REUTERS

Biome Australia - Agreement Requires No Upfront Capital Investment From Biome

THOMSON REUTERS

Biome Australia - Gross Margin Expected to Increase From 61% to Over 65% Over Next 18 Months

THOMSON REUTERS

Biome Australia - to Retain European Supply Partnerships for EU Markets

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/BIO.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BIO.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BIO.AU\",,,,,undefined,":{"symbol":"BIO.AU","market":"AU","secType":"STK","nameCN":"BIOME AUSTRALIA LTD","latestPrice":0.275,"timestamp":1787548743555,"preClose":0.27,"halted":0,"volume":59400,"delay":0,"changeRate":0.018518518518518535,"nameEN":"BIOME AUSTRALIA LTD","floatShares":121511476,"shares":226998033,"eps":0.0042,"marketStatus":"Trading","change":0.005,"latestTime":"08-24 15:55:04 AEST","open":0.27,"high":0.275,"low":0.267,"amount":16037,"amplitude":0.02963,"askPrice":0.27,"askSize":8380,"bidPrice":0.265,"bidSize":29519,"shortable":3,"etf":0,"ttmEps":0.0042,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787551200000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.27,"openAndCloseTimeList":[[1787529600000,1787551200000]],"volumeRatio":0.386127,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"BIO.AU","preClose":0.27,"auctionPrice":0.27,"auctionVolume":472,"auctionTime":1787529539124,"referenceTime":1787308204093,"auction":1,"marketStatus":"盘前竞价","timestamp":1787529539124}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BIO.AU\",,,,,undefined,":{"symbol":"BIO.AU","floatShares":121511476,"roa":"3.02%","roe":"18.09%","lyrEps":0.000982,"volumeRatio":0.386127,"shares":226998033,"dividePrice":0,"high":0.275,"amplitude":0.02963,"preClose":0.27,"low":0.267,"week52Low":0.2,"pbRate":"10.30","psRate":"2.84","week52High":0.56,"institutionHeld":0,"latestPrice":0.275,"committee":0.557772,"eps":0.0042,"divideRate":0,"volume":59400,"delay":0,"ttmEps":0.0042,"open":0.27,"prevYearClose":0.42,"prevWeekClose":0.27,"prevMonthClose":0.28,"prevQuarterClose":0.265,"fiveDayClose":0.27,"twentyDayClose":0.27,"sixtyDayClose":0.232},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIO.AU\",params:#limit:5,,,undefined,":[{"date":"2026-07-29","symbol":"BIO.AU","type":"earning","reportTimeType":"pre","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1785283200000,"name":null,"time":"Pre-MKt","dateTimestamp":1785247200000,"actualEps":null},{"date":"2026-02-22","symbol":"BIO.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771714800000,"name":null,"time":"","dateTimestamp":1771678800000,"actualEps":null},{"date":"2024-02-27","symbol":"BIO.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1708988400000,"name":null,"time":"","dateTimestamp":1708952400000,"actualEps":null},{"date":"2024-01-30","symbol":"BIO.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1706569200000,"name":null,"time":"","dateTimestamp":1706533200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIO.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BIO.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657432666","title":"RBC Adjusts PT on Bio-Rad Laboratories to $390 From $370, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2657432666","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657432666?lang=en_us&edition=fundamental","pubTime":"2026-08-07 20:12","pubTimestamp":1786104728,"startTime":"0","endTime":"0","summary":"Bio-Rad Laboratories (BIO) has an average rating of hold and mean price target of $341.25, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from maj","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BIO","BIO.B","BK4585","BK4121","BIO.AU","LU1169589451.USD","BK4588","BK7111","LU1169590202.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657254481","title":"RBC Adjusts Price Target on Bio-Rad Laboratories to $370 From $320, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2657254481","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657254481?lang=en_us&edition=fundamental","pubTime":"2026-08-05 20:06","pubTimestamp":1785931574,"startTime":"0","endTime":"0","summary":"Bio-Rad Laboratories (BIO) has an average rating of hold and mean price target of $336.25, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from maj","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4585","BIO.B","BIO","BK7111","BK4121","LU1169589451.USD","LU1169590202.USD","BIO.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655841200","title":"ASX Penny Stocks To Watch: Biome Australia And Two More Compelling Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2655841200","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655841200?lang=en_us&edition=fundamental","pubTime":"2026-07-30 10:08","pubTimestamp":1785377317,"startTime":"0","endTime":"0","summary":"The Australian share market is experiencing turbulence, with recent declines influenced by rising U.S. bond yields and inflation concerns impacting global indices. In such a volatile landscape, investors may find opportunities in penny stocks, which despite their outdated name, continue to offer potential value particularly among smaller or newer companies. By focusing on those with strong financial foundations, these stocks can present promising prospects for long-term growth amidst current...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/5221000-choice2-main-header/1585186851278","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/5221000-choice2-main-header/1585186851278"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/household/asx-bio/biome-australia-shares/news/asx-penny-stocks-to-watch-biome-australia-and-two-more-compe","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/household/asx-bio/biome-australia-shares/news/asx-penny-stocks-to-watch-biome-australia-and-two-more-compe","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["E200.AU","IMLC.AU","QFN.AU","GDG.AU","BEAR.AU","QRE.AU","EIGA.AU","VAS.AU","XJO.AU","GIVE.AU","STW.AU","OZR.AU","BK7089","BK7058","DACE.AU","IIGF.AU","IISV.AU","XKO.AU","IOZ.AU","XAO.AU","BBOZ.AU","VAP.AU","OZF.AU","BK7111","GEAR.AU","KSC.AU","SLF.AU","BIO.AU","ZYAU.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655083669","title":"Biome Australia - FY26 Sales Revenue Rises 30% to A$23.9 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2655083669","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655083669?lang=en_us&edition=fundamental","pubTime":"2026-07-29 06:41","pubTimestamp":1785278510,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nFWN43U1FV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BIO.AU","BK7111"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650157626","title":"Bio Rad Laboratories (BIO) Launches New ddPCR Kits Following A Fair Value Debate","url":"https://stock-news.laohu8.com/highlight/detail?id=2650157626","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650157626?lang=en_us&edition=fundamental","pubTime":"2026-07-12 08:30","pubTimestamp":1783816221,"startTime":"0","endTime":"0","summary":"Bio-Rad Laboratories (BIO) has introduced its QX700 System-compatible Vericheck ddPCR Kit portfolio, targeting quality control workflows in advanced cell and gene therapy development and broader biopharma applications, an event that may influence how investors assess the stock.\nSee our latest analysis for Bio-Rad Laboratories.\nAt a share price of US$296.11, Bio-Rad Laboratories has seen modest recent momentum, with a 30-day share price return of 1.75% and a 90-day gain of 6.04%. The 1-year...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-bio/bio-rad-laboratories/news/bio-rad-laboratories-bio-launches-new-ddpcr-kits-following-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-bio/bio-rad-laboratories/news/bio-rad-laboratories-bio-launches-new-ddpcr-kits-following-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BIO.B","BK7111","BK4588","BK4121","BIO","BIO.AU","LU1169589451.USD","LU1169590202.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649964482","title":"Biome Australia Logs FY Revenue of AUD 23.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2649964482","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649964482?lang=en_us&edition=fundamental","pubTime":"2026-07-06 15:45","pubTimestamp":1783323911,"startTime":"0","endTime":"0","summary":"July 1 (Reuters) - Biome Australia Ltd::*FY REVENUE AUD 23.9 MILLION*VISION 27 TARGETS CUMULATIVE SALES REVENUE OF AT LEAST A$75M ACROSS FY25 TO FY27*Further company coverage: BIO.AX* ((Reuters.Briefs","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nRSD78jpnb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7111","BIO.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648591349","title":"Biome Australia Hits Two-month High on Upbeat Full-year Sales Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2648591349","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648591349?lang=en_us&edition=fundamental","pubTime":"2026-07-01 10:55","pubTimestamp":1782874544,"startTime":"0","endTime":"0","summary":"BUZZ-Biome Australia hits two-month high on upbeat full-year sales revenue** Shares of Biome AustraliaBIO.AXclimb as much as 17% to A$0.31, their highest level since April 28** On track to log its bes","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nL6N43306K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7111","BIO.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648596142","title":"Biome Australia Logs FY Revenue of AUD 23.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2648596142","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648596142?lang=en_us&edition=fundamental","pubTime":"2026-07-01 09:30","pubTimestamp":1782869416,"startTime":"0","endTime":"0","summary":"BRIEF-Biome Australia Logs FY Revenue of AUD 23.9 MillionJuly 1 (Reuters)-Biome Australia LtdBIO.AX:FY REVENUE AUD 23.9 MILLIONVISION 27 TARGETS CUMULATIVE SALES REVENUE OF AT LEAST A$75M ACROSS FY25 TO FY27Further company coverage:BIO.AX","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nPLX21FPZW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIO.AU","BK7111"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648772560","title":"Biome Australia Ltd - Vision 27 Targets Cumulative Sales Revenue of at Least A$75m Across FY25 to FY27","url":"https://stock-news.laohu8.com/highlight/detail?id=2648772560","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648772560?lang=en_us&edition=fundamental","pubTime":"2026-07-01 06:36","pubTimestamp":1782858980,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nPLX21FPZW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7111","BIO.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644098874","title":"Bio Protocol launches AI research hub to challenge grant gatekeepers","url":"https://stock-news.laohu8.com/highlight/detail?id=2644098874","media":"cryptonews","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644098874?lang=en_us&edition=fundamental","pubTime":"2026-06-20 20:53","pubTimestamp":1781959988,"startTime":"0","endTime":"0","summary":"Bio Protocol has launched OpenLabs, a platform that combines AI-assisted research development, community funding, and on-chain governance as its ecosystem surpasses $33 million in capital raised.Bio Protocol launched OpenLabs, combining AI-assisted research development, collaboration, and funding in one platform.Bio Protocol said its BIO Genesis initiative has raised over $33 million to support decentralized science projects.According to Bio Protocol, the platform was introduced on June 19 during DeSci.Berlin 2026, an event held at KNIG GALERIE as part of Berlin Blockchain Week.At the event, Bio Protocol presented OpenLabs as an alternative to traditional research funding processes, which often involve lengthy review cycles and institutional oversight. The project stated that community members can vote on research proposals while AI-powered workflows assist researchers in developing and refining projects.Despite the launch, Bio Protocol  continued to trade lower alongside the broader c","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"crypto_news_highlight","url":"https://crypto.news/bio-protocol-launches-ai-research-hub-to-challenge-grant-gatekeepers/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://crypto.news/bio-protocol-launches-ai-research-hub-to-challenge-grant-gatekeepers/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"crypto_news_highlight","symbols":["AIPO","BK4121","BK4588","ARTY","AGIX","BK4585","BIO","BIO.AU","CHAT","LU1169590202.USD","BK7111","LU1169589451.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644033439","title":"How Stronger Results and Institutional Selling At Bio-Rad Laboratories (BIO) Has Changed Its Investment Story","url":"https://stock-news.laohu8.com/highlight/detail?id=2644033439","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644033439?lang=en_us&edition=fundamental","pubTime":"2026-06-19 02:25","pubTimestamp":1781807109,"startTime":"0","endTime":"0","summary":"Recently, Bio-Rad Laboratories reported year-over-year growth in both revenue and net profit while institutional investors, led by First Eagle Investment, significantly reduced their holdings and technical indicators leaned toward selling.\nThis contrast between strengthening financial results and declining institutional ownership, alongside neutral-to-weak technical signals, raises fresh questions about how different investor groups are interpreting Bio-Rad’s underlying business...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-bio/bio-rad-laboratories/news/how-stronger-results-and-institutional-selling-at-bio-rad-la","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-bio/bio-rad-laboratories/news/how-stronger-results-and-institutional-selling-at-bio-rad-la","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4121","BK4588","LU1169589451.USD","BIO.AU","LU1169590202.USD","BK4585","BIO.B","BK7111","BIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642428077","title":"Does New MicroVal Approval Clarify Bio-Rad (BIO)’s Competitive Edge in Food Safety Testing?","url":"https://stock-news.laohu8.com/highlight/detail?id=2642428077","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642428077?lang=en_us&edition=fundamental","pubTime":"2026-06-11 21:21","pubTimestamp":1781184062,"startTime":"0","endTime":"0","summary":"Bio-Rad Laboratories recently announced that MicroVal approved its EZ-Check Listeria spp. and Listeria monocytogenes detection kits, confirming they meet ISO 16140-2 standards for use in food products and environmental samples.\nThis additional international validation, alongside earlier AOAC recognition, strengthens confidence in Bio-Rad’s food safety testing portfolio and its global regulatory credibility.\nWe’ll now examine how this added MicroVal validation for Bio-Rad’s Listeria detection...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-bio/bio-rad-laboratories/news/does-new-microval-approval-clarify-bio-rad-bios-competitive","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-bio/bio-rad-laboratories/news/does-new-microval-approval-clarify-bio-rad-bios-competitive","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BIO.AU","BIO","BK4121","LU1169590202.USD","BIO.B","BK4585","BK4588","BK7111","LU1169589451.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641179927","title":"ASX Penny Stocks With Market Caps Under A$200M To Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2641179927","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641179927?lang=en_us&edition=fundamental","pubTime":"2026-06-08 03:02","pubTimestamp":1780858971,"startTime":"0","endTime":"0","summary":"Over the last 7 days, the Australian market has dropped 1.2%, remaining relatively flat over the past year, with earnings forecasted to grow by 12% annually. Investing in penny stocks—typically smaller or newer companies—can still open doors to growth opportunities when these stocks are backed by strong financial health. This article will explore several penny stocks that stand out as hidden gems, offering potential for impressive returns amidst current market conditions.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-ltp/ltr-pharma-shares/news/asx-penny-stocks-with-market-caps-under-a200m-to-watch","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-ltp/ltr-pharma-shares/news/asx-penny-stocks-with-market-caps-under-a200m-to-watch","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["E200.AU","GIVE.AU","XAO.AU","LTP.AU","BK7096","CUE.AU","GEAR.AU","IMLC.AU","OZR.AU","IIGF.AU","IOZ.AU","XKO.AU","BBOZ.AU","ZYAU.AU","QRE.AU","STW.AU","BIO.AU","SLF.AU","VAP.AU","XJO.AU","OZF.AU","IISV.AU","BK7111","BEAR.AU","EIGA.AU","VAS.AU","DACE.AU","BK7142","QFN.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640922082","title":"Biome Signs Binding Commercial Manufacturing Agreement for Activated Probiotics Products in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2640922082","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640922082?lang=en_us&edition=fundamental","pubTime":"2026-06-03 09:16","pubTimestamp":1780449418,"startTime":"0","endTime":"0","summary":"Biome Australia  signed a binding commercial manufacturing agreement with Specialty Probiotics Australia, with an initial term of two years, as it seeks to transition manufacturing of its Activated Probiotics range to Australia, according to a Wednesday Australian bourse filing.The agreement requires no capital expenditure from Biome, and production in Australia will occur in smaller, more frequent batches. The first commercial batch is targeted for September, with the remaining range expected to move over around the following 18 months, subject to successful commercial scale-up and transition of production.Biome will supply the active ingredients, and Specialty Probiotics will carry out domestic manufacture and finishing.Biome will maintain its supply relationships with its European manufacturing partners to continue servicing European markets.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XJO.AU","QFN.AU","XKO.AU","VAS.AU","EIGA.AU","BEAR.AU","ZYAU.AU","QRE.AU","GIVE.AU","GEAR.AU","IISV.AU","BIO.AU","BK7111","SLF.AU","E200.AU","IMLC.AU","IIGF.AU","OZF.AU","IOZ.AU","OZR.AU","BBOZ.AU","XAO.AU","DACE.AU","VAP.AU","STW.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640922696","title":"BUZZ-Biome Australia soars on signing Australian manufacturing deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2640922696","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640922696?lang=en_us&edition=fundamental","pubTime":"2026-06-03 08:53","pubTimestamp":1780448023,"startTime":"0","endTime":"0","summary":"BUZZ-Biome Australia soars on signing Australian manufacturing deal** Shares of Biome Australia BIO.AX rise as much as 22.2% to A$0.275, post their steepest intraday pct gain since late-May 2024** Stock hits highest level since May 18** Biotherapeutics maker signs commercial manufacturing agreement with Specialty Probiotics Australia to bring production of its activated probiotics range onshore** About 537,000 shares change hands, 2.2 times the 30-day avg ** Stock down 35.7% YTD, including the session's moves  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nL6N42B01V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIO.AU","BK7111"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640929044","title":"Biome Australia - Signs Manufacturing Agreement to Bring Activated Probiotics Production Onshore","url":"https://stock-news.laohu8.com/highlight/detail?id=2640929044","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640929044?lang=en_us&edition=fundamental","pubTime":"2026-06-03 06:43","pubTimestamp":1780440226,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nTUE7TQ85K:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BIO.AU","BK7111"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640921833","title":"Biome Australia - First Commercial Batch Targeted for September 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2640921833","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640921833?lang=en_us&edition=fundamental","pubTime":"2026-06-03 06:43","pubTimestamp":1780440226,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nTUE7TQ85K:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7111","BIO.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640835921","title":"Biome Australia - Agreement Requires No Upfront Capital Investment From Biome","url":"https://stock-news.laohu8.com/highlight/detail?id=2640835921","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640835921?lang=en_us&edition=fundamental","pubTime":"2026-06-03 06:43","pubTimestamp":1780440226,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nTUE7TQ85K:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7111","BIO.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640290419","title":"Biome Australia - Gross Margin Expected to Increase From 61% to Over 65% Over Next 18 Months","url":"https://stock-news.laohu8.com/highlight/detail?id=2640290419","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640290419?lang=en_us&edition=fundamental","pubTime":"2026-06-03 06:43","pubTimestamp":1780440226,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nTUE7TQ85K:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7111","BIO.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640218389","title":"Biome Australia - to Retain European Supply Partnerships for EU Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2640218389","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640218389?lang=en_us&edition=fundamental","pubTime":"2026-06-03 06:43","pubTimestamp":1780440226,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nTUE7TQ85K:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BIO.AU","BK7111"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":38,"code":"91000000","status":"200"}]}}